269 related articles for article (PubMed ID: 33472456)
1. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis.
Ren L; Zhou H; Lei L; Zhang Y; Cai H; Wang X
Bioengineered; 2021 Dec; 12(1):5266-5278. PubMed ID: 34424807
[TBL] [Abstract][Full Text] [Related]
3. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
4. Deletion of
Meng Q; Wang L; Lv Y; Wu J; Shi W
Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
[No Abstract] [Full Text] [Related]
5. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
Ma Y; Bu D; Long J; Chai W; Dong J
J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
[TBL] [Abstract][Full Text] [Related]
7. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
8. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
[TBL] [Abstract][Full Text] [Related]
10. N
Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
[No Abstract] [Full Text] [Related]
12. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
13. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
[TBL] [Abstract][Full Text] [Related]
14. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2.
Dong G; Wang X; Jia Y; Jia Y; Zhao W; Zhang J; Tong Z
Biomed Res Int; 2020; 2020():8124570. PubMed ID: 33015182
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4.
Bi Y; Mao Y; Su Z; Du J; Ye L; Xu F
J Cell Physiol; 2021 Feb; 236(2):1068-1082. PubMed ID: 32779194
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
Lu PW; Li L; Wang F; Gu YT
J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
Zhang G; An X; Zhao H; Zhang Q; Zhao H
Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
[TBL] [Abstract][Full Text] [Related]
18. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
[TBL] [Abstract][Full Text] [Related]
19. ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer.
Kim HW; Baek M; Jung S; Jang S; Lee H; Yang SH; Kwak BS; Kim SJ
Epigenetics; 2023 Dec; 18(1):2276384. PubMed ID: 37908128
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
